ArticleCancer medicine2024

Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018-2021) compared to the sorafenib era (2008-2018).

Chloe A Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.